详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

A pan-cancer analysis of the oncogenic and immunological roles of transglutaminase 1 (TGM1) in human cancer

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of Urology, Institute of Urology, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, China [2]Research Core Facilities, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, People’s Republic of China [3]Department of Urology, The Second Afliated Hospital of Anhui Medical University, Hefei 230601, China [4]Department of Rehabilitation, West Kyushu University, Fukuoka, Japan [5]Department of Urology, Kyung Hee University, Seoul, South Korea [6]Department of Rehabilitation, The Afliated Hospital of Southwest Medical University, Luzhou 646000, People’s Republic of China

出处：

DOI：

ISSN：

关键词： Pan-cancer biomarker Tumor-infltrating cells Transglutaminase 1

摘要：

There is currently a limited number of studies on transglutaminase type 1 (TGM1) in tumors. The objective of this study is to perform a comprehensive analysis across various types of cancer to determine the prognostic significance of TGM1 in tumors and investigate its role in the immune environment.Pan-cancer and mutational data were retrieved from the TCGA database and analyzed using R (version 3.6.4) and its associated software package. The expression difference and prognosis of TGM1 were examined, along with its correlation with tumor heterogeneity, stemness, mutation landscape, and RNA modification. Additionally, the relationship between TGM1 expression and tumor immunity was investigated using the TIMER method.TGM1 is expressed differently in various tumors and normal samples and is associated with the overall survival and progression-free time of KIRC, ACC, SKCM, LIHC, and STES. In LICH, we found a negative correlation between TGM1 expression and 6 indicators of tumor stemness. The mutation frequencies of BLCA, LIHC, and KIRC were 1.7%, 0.3%, and 0.3% respectively. In BLCA and BRCA, there was a significant correlation between TGM1 expression and the infiltration of CD4 + T cells, CD8 + T cells, neutrophils, and dendritic cells.TGM1 has the potential to serve as both a prognostic marker and a drug target.© 2024. The Author(s).

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 3 区医学

小类 | 4 区肿瘤学

最新[2023]版：

大类 | 3 区医学

小类 | 4 区肿瘤学

第一作者：

第一作者机构： [1]Department of Urology, Institute of Urology, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, China

共同第一作者：

通讯作者：

通讯机构： [1]Department of Urology, Institute of Urology, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, China [6]Department of Rehabilitation, The Afliated Hospital of Southwest Medical University, Luzhou 646000, People’s Republic of China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers [2]Utility of G protein-coupled oestrogen receptor 1 as a biomarker for pan-cancer diagnosis, prognosis and immune infiltration: a comprehensive bioinformatics analysis [3]医院后勤精细化管理策略研究 [4]个性化目标教学在神经外科护理实习生带教中的应用 [5]纳米增强免疫比浊法和高效液相色谱法检测化疗患者5-氟尿嘧啶血药浓度的比较 [6]徒手淋巴引流对乳腺癌术后淋巴水肿的治疗效果分析 [7]护理干预在减轻妇科恶性肿瘤腹部术后疼痛中的效果 [8]心理护理对肿瘤介入治疗患者生活质量的影响 [9]某院2400张门诊中成药处方分析 [10]人文关怀在恶性肿瘤护理中的应用效果分析